Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sachiyo Hanamuro"'
Autor:
Shinichiro Maeda, Takuya Shintani, Sachiyo Hanamuro, Ying Lin, Yuya Haga, Kazuma Higashisaka, Yasushi Fujio, Yasuo Tsutsumi, Hirofumi Tsujino, Ayaka Maki, Kazuya Nagano
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-10 (2020)
Scientific Reports
Scientific Reports
In non-small-cell lung cancer, mutation of epidermal growth factor receptor (EGFR) stimulates cell proliferation and survival. EGFR tyrosine kinase inhibitors (EGFR-TKIs) such as erlotinib are used as first-line therapy with drastic and immediate eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6da94f0dd932556b0f63f1b12a7ed51
http://link.springer.com/article/10.1038/s41598-020-61727-3
http://link.springer.com/article/10.1038/s41598-020-61727-3
Autor:
Kazuma Higashisaka, Kazuya Nagano, Sachiyo Hanamuro, Hiroto Konishi, Yuya Haga, Lili Yang, Ying Lin, Hirofumi Tsujino, Yasuo Tsutsumi, Kohei Izusawa
Publikováno v:
Molecular Cancer Therapeutics. 18:B114-B114
To overcome the resistance of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) in non-small cell lung cancer, the mechanism clarification and novel molecular target development are urgently required. From this viewpoint, we previ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdb50d2cfd054e88cdc9b05729607301
https://doi.org/10.1158/1535-7163.targ-19-b114
https://doi.org/10.1158/1535-7163.targ-19-b114